<?xml version="1.0" encoding="UTF-8"?>
<ref id="b108-ir-2019-09155">
 <label>108</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>HY</given-names>
   </name>
  </person-group>
  <article-title>Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation</article-title>
  <source>Ann Hepatol</source>
  <year>2016</year>
  <volume>15</volume>
  <fpage>501</fpage>
  <lpage>511</lpage>
  <pub-id pub-id-type="pmid">27236149</pub-id>
 </element-citation>
</ref>
